摘要
在第I部分中 ,已经报告了芍药甘草汤 (SGT)的连续给药提高了SGT中甘草酸 (glycyrrhizin,GL)的生物利用度。在本文 ,即本研究的第II部分 ,对在溃疡治疗中常和SGT合用的西药 ,如组织胺H2 受体拮抗剂cimetidine,抗胆碱药scopolaminebutylbromide(SBB) ,由一个质子泵抑制剂 (omeprazole,OPZ)和两种抗菌剂(amoxicillin,AMPC,andmetronidazole,MET)所组成的三剂疗法OAM等 ,对于SGT中GL生物利用度的影响进行了考察。实验结果显示 ,cimetidine或SBB的合用对SGT中GL的生物利用度没有显著影响 ,但OAM的合用却有显著的降低作用。OAM降低作用的要因药物经实验证明为抗菌剂组合AMPC_MET ,而非质子泵抑制剂OPZ。AMPC_MET作用的原因机制在于其显著地降低了肠内细菌的将GL代谢成甘草次酸 (18β_glycyrrheticacid,GA)的活性。该结果表明 ,含有AMPC_MET的三剂疗法如OAM等不适合和SGT同时给药。
In part I,we reported that the repetitive administration of Shaoyao-Gancao-Tang(SGT)increased the bioavailability of glycyrrhizin(GL)in SGT.In clinic,SGT is sometimes used together with some synthetic drugs.In this partⅡ,the influences of co-administered synthetic drugs on the pharmacokinetic fate of GL from SGT were investigated.The results showed that the co-administration of either a histamine2-receptor antagonist(cimetidine)or an anticholinergic drug(scopolamine butyl bromide,SBB)did not clearly influence the bioavailˉability of GL in SGT.However,the co-administration of a triple therapy OAM consisting of a proton pump inˉhibitor(omeprazole,OPZ)and two antibacterial drugs(amoxicillin,AMPC,and metronidazole,MET)markedly reduced the plasma GA concentration.The reduction of plasma GA by OAM was shown to be due to the anˉtibacterial drugs AMPC-MET,not the proton pump inhibitor OPZ.The mechanism of the reduction by AMˉPC-MET involved the severe decrease of the GL-metabolizing activity of intestinal bacteria by AMPC-MET.These results suggest that it is not appropriate to simultaneously administer AMPC-MET with SGT.
出处
《天津中医药》
CAS
2004年第5期426-429,共4页
Tianjin Journal of Traditional Chinese Medicine
关键词
药物相互作用
芍药甘草汤
西药
甘草酸
药动学
肠内细菌
代谢活性
drug-drug interaction
Shaoyao-Gancao-Tang
antibacterial drugs
glycyrrhizin
pharmacokiˉnetics
intestinal bacteria